Table 1.
Amlodipine |
Cilnidipine |
Candesartan |
||||||
---|---|---|---|---|---|---|---|---|
C | 2W | 4W | C | 2W | 4W | C | 4W | |
STV (ms) | 3.8 ± 0.6 | 4.3 ± 1.1 | 5.0 ± 0.7 | 4.2 ± 1.2 | 1.8 ± 0.4* | 2.2 ± 0.4* | 4.1 ± 0.8 | 5.2 ± 0.9 |
LTV (ms) | 2.4 ± 0.4 | 3.1 ± 1.2 | 3.3 ± 0.8 | 2.0 ± 0.5 | 1.4 ± 0.3 | 1.7 ± 0.3 | 2.6 ± 0.6 | 3.3 ± 0.6 |
Short-term variability (STV) and long-term variability (LTV) of the MAP duration in the amlodipine and cilnidipine groups were obtained at pre-drug control (C) and 2 weeks (2W) and 4 weeks (4W) after the start of drug administration, whereas those in the candesartan group were obtained at pre-drug control and 4 weeks after the start of drug administration. Data are presented as the mean ± SEM.
P < 0.05, compared with corresponding pre-drug control value.